|
SLC35A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.094400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.495570E-02 |
| Normal-vs-Stage2 |
6.249200E-01 |
| Normal-vs-Stage3 |
8.476600E-01 |
| Normal-vs-Stage4 |
1.404360E-01 |
| Stage1-vs-Stage2 |
1.135980E-02 |
| Stage1-vs-Stage3 |
1.499950E-02 |
| Stage1-vs-Stage4 |
3.875000E-03 |
| Stage2-vs-Stage3 |
7.849400E-01 |
| Stage2-vs-Stage4 |
4.800000E-01 |
| Stage3-vs-Stage4 |
3.399800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.346200E-02 |
| Normal-vs-AfricanAmerican |
6.825600E-01 |
| Normal-vs-Asian |
9.321000E-01 |
| Caucasian-vs-AfricanAmerican |
1.729400E-01 |
| Caucasian-vs-Asian |
4.250200E-01 |
| AfricanAmerican-vs-Asian |
7.807800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.567800E-02 |
| Normal-vs-Female |
5.662200E-01 |
| Male-vs-Female |
2.096600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.099800E-01 |
| Normal-vs-Extreme_Weight |
9.702900E-03 |
| Normal-vs-Obese |
3.401000E-01 |
| Normal-vs-Extreme_Obese |
2.249200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.239190E-01 |
| Normal_Weight-vs-Obese |
8.349400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.201400E-01 |
| Extreme_Weight-vs-Obese |
5.205500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.105000E-01 |
| Obese-vs-Extreme_Obese |
6.250400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.256800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.773200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.455900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.216150E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.311800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.847700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.750300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.960300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.961800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.695200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.784800E-01 |
| Normal-VS-Type2 PRCC |
7.644100E-03 |
| Normal-VS-KIRP CIMP |
2.046000E-02 |
| Normal-VS-Unclassified PRCC |
1.248160E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.179800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.978700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.334600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.097100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.878000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.628150E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.542200E-02 |
| Normal-vs-N1 |
1.112950E-01 |
| Normal-vs-N2 |
2.433400E-01 |
| N0-vs-N1 |
8.190600E-04 |
| N0-vs-N2 |
9.916800E-01 |
| N1-vs-N2 |
1.649240E-01 |
|
|
